JP2002526550A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526550A5
JP2002526550A5 JP2000574548A JP2000574548A JP2002526550A5 JP 2002526550 A5 JP2002526550 A5 JP 2002526550A5 JP 2000574548 A JP2000574548 A JP 2000574548A JP 2000574548 A JP2000574548 A JP 2000574548A JP 2002526550 A5 JP2002526550 A5 JP 2002526550A5
Authority
JP
Japan
Prior art keywords
alkyl
bond
amino acid
acid group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574548A
Other languages
English (en)
Japanese (ja)
Other versions
JP4598953B2 (ja
JP2002526550A (ja
Filing date
Publication date
Priority claimed from DE19845403A external-priority patent/DE19845403B4/de
Application filed filed Critical
Publication of JP2002526550A publication Critical patent/JP2002526550A/ja
Publication of JP2002526550A5 publication Critical patent/JP2002526550A5/ja
Application granted granted Critical
Publication of JP4598953B2 publication Critical patent/JP4598953B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000574548A 1998-10-02 1999-09-18 脂質代謝障害を治療するための胆汁酸と結合したプロパノールアミン誘導体 Expired - Fee Related JP4598953B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19845403.1 1998-10-02
DE19845403A DE19845403B4 (de) 1998-10-02 1998-10-02 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PCT/EP1999/006930 WO2000020437A1 (de) 1998-10-02 1999-09-18 Mit gallensäuren verknüpfte propanolaminderivate zur behandlung von lipidstoffwechselstörungen

Publications (3)

Publication Number Publication Date
JP2002526550A JP2002526550A (ja) 2002-08-20
JP2002526550A5 true JP2002526550A5 (https=) 2006-09-07
JP4598953B2 JP4598953B2 (ja) 2010-12-15

Family

ID=7883185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574548A Expired - Fee Related JP4598953B2 (ja) 1998-10-02 1999-09-18 脂質代謝障害を治療するための胆汁酸と結合したプロパノールアミン誘導体

Country Status (22)

Country Link
US (1) US6180618B1 (https=)
EP (1) EP1117676B1 (https=)
JP (1) JP4598953B2 (https=)
KR (1) KR20010075511A (https=)
CN (1) CN1227259C (https=)
AR (1) AR035003A1 (https=)
AT (1) ATE273991T1 (https=)
AU (1) AU757366B2 (https=)
BR (1) BR9915019A (https=)
CA (1) CA2346085A1 (https=)
DE (2) DE19845403B4 (https=)
DK (1) DK1117676T3 (https=)
ES (1) ES2226440T3 (https=)
HK (1) HK1040717A1 (https=)
HU (1) HUP0103570A3 (https=)
ID (1) ID29353A (https=)
PL (1) PL347106A1 (https=)
PT (1) PT1117676E (https=)
RU (1) RU2234512C2 (https=)
TR (1) TR200100897T2 (https=)
WO (1) WO2000020437A1 (https=)
ZA (1) ZA200102586B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A7 (fi) 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
GB2250634A (en) * 1990-12-04 1992-06-10 Marconi Gec Ltd Point contact diodes
NZ240846A (en) 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
JP2616845B2 (ja) * 1991-02-21 1997-06-04 清水化学株式会社 システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
TW289021B (https=) * 1993-05-08 1996-10-21 Hoechst Ag
EP0624593A3 (de) 1993-05-08 1995-06-07 Hoechst Ag Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater

Similar Documents

Publication Publication Date Title
JP2001526218A5 (https=)
JP2002517491A5 (https=)
JP2002519425A5 (https=)
JP2003531118A5 (https=)
JP2010530881A5 (https=)
JP2001525359A5 (https=)
JP2002508361A5 (https=)
JP2002526550A5 (https=)
JP2003502367A5 (https=)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2004514663A5 (https=)
JP2002543202A5 (https=)
JP2002518502A5 (https=)
JP2002531498A5 (https=)
JP2003519228A5 (https=)
JP2002520282A5 (https=)
JP2002525323A5 (https=)
JP2002506864A5 (https=)
JP2002503714A5 (https=)
JP2002522501A5 (https=)
JPH10147529A5 (https=)
JP2003520208A5 (https=)
JP2002520286A5 (https=)
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JP2002526530A5 (https=)